Cicor Technologies (CICN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
5 Aug, 2026Executive summary
Revenue grew 19% year-over-year to CHF 334.1 million, driven by acquisitions and a return to organic growth in Q2.
Order intake surged 39.8% to CHF 399.8 million, with a book-to-bill ratio of 1.2 for the fifth consecutive quarter, indicating strong business momentum.
Integration of 2025 acquisitions is largely complete, with operational synergies and annual savings above CHF 10 million expected.
Workforce reduced by 5% (220 employees) through site divestments and consolidation.
Net profit and EPS impacted by integration expenses and unfavorable FX; free cash flow negative due to working capital build-up.
Financial highlights
H1 2026 revenue reached CHF 334.1 million, up 19% year-over-year; core driver was M&A (+22.8%), partially offset by -3.8% FX impact.
Adjusted EBITDA was CHF 28.0 million (margin 8.4%), down from CHF 29.0 million (10.3%) due to integration costs and lower margins from acquired businesses.
Adjusted EBIT at CHF 19.1 million (5.7% margin), down from CHF 21.4 million (7.6%).
Adjusted net profit at CHF 12.2 million, with adjusted EPS of CHF 2.76, both slightly down year-over-year.
Free cash flow before M&A at CHF -11.5 million, reflecting increased working capital.
Outlook and guidance
Full-year 2026 revenue guidance confirmed at CHF 700–750 million, with adjusted EBITDA expected at CHF 70–80 million.
Sequential revenue and EBITDA growth of 10–25% expected in H2, mostly organic, contingent on supply chain execution.
Integration efficiency program to deliver CHF 10 million annualized savings, with most benefits visible from H2 onward.
Robust double-digit adjusted EBITDA margin anticipated in H2 due to completed integration and efficiency measures.
Guidance assumes no further geopolitical or macroeconomic deterioration.
Latest events from Cicor Technologies
- Achieved 28.2% sales growth in 2025 and targets CHF 700-750 million sales for 2026.CICN
Investor presentation - Q1 sales up 22.6% to CHF 160.7M, with strong A&D orders and positive 2026 outlook.CICN
Q1 2026 - 2025 sales surged 28.2% to CHF 616.5 million, fueled by acquisitions and sector growth.CICN
Investor presentation - Revenue up 28% to CHF 616.5–660m, five acquisitions, and strong 2026 outlook.CICN
Q4 2025 - Transformational acquisition forms the largest global HMLV EMS provider, driving growth and synergies.CICN
M&A Announcement (Media) - Sales up 21.4% year-over-year, guidance raised on strong M&A and Q2 organic growth.CICN
H1 2025 - Ambitious 2028 targets CHF 1B+ revenue via M&A, innovation, and operational excellence.CICN
CMD 2024 Presentation - Net profit rose 53.9% as acquisitions drove record sales and upgraded guidance.CICN
H1 2024 - Record sales, profit, and cash flow in 2024 set the stage for continued growth in 2025.CICN
H2 2024